Sally Bebawy

1.7k total citations
21 papers, 646 citations indexed

About

Sally Bebawy is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Sally Bebawy has authored 21 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 8 papers in Epidemiology and 8 papers in Emergency Medicine. Recurrent topics in Sally Bebawy's work include HIV/AIDS Research and Interventions (18 papers), HIV-related health complications and treatments (8 papers) and HIV Research and Treatment (6 papers). Sally Bebawy is often cited by papers focused on HIV/AIDS Research and Interventions (18 papers), HIV-related health complications and treatments (8 papers) and HIV Research and Treatment (6 papers). Sally Bebawy collaborates with scholars based in United States and Brazil. Sally Bebawy's co-authors include Timothy R. Sterling, Megan Turner, Bryan E. Shepherd, Peter F. Rebeiro, Stephen Raffanti, Todd Hulgan, John R. Koethe, David W. Haas, Samuel E. Stinnette and Asghar Kheshti and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Sally Bebawy

18 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sally Bebawy United States	12	457	319	240	177	80	21	646
Megan Turner United States	14	637 1.4×	525 1.6×	306 1.3×	199 1.1×	65 0.8×	39	910
Mary van den Berg-Wolf United States	11	504 1.1×	163 0.5×	334 1.4×	135 0.8×	60 0.8×	14	645
Daniel Seekins United States	19	532 1.2×	161 0.5×	324 1.4×	211 1.2×	43 0.5×	30	746
Rennatus Mdodo United States	8	298 0.7×	170 0.5×	69 0.3×	178 1.0×	63 0.8×	10	489
Carlin Rafie United States	10	351 0.8×	123 0.4×	168 0.7×	293 1.7×	139 1.7×	19	670
Marcel Stoeckle Switzerland	14	336 0.7×	101 0.3×	152 0.6×	169 1.0×	41 0.5×	54	517
Shelly Sun United States	14	417 0.9×	143 0.4×	143 0.6×	259 1.5×	52 0.7×	23	660
Nomathemba Chandiwana South Africa	9	474 1.0×	372 1.2×	248 1.0×	105 0.6×	36 0.5×	26	628
Ignacio Pérez Spain	12	366 0.8×	286 0.9×	311 1.3×	57 0.3×	38 0.5×	25	616
Celicia Serenata South Africa	12	654 1.4×	376 1.2×	352 1.5×	184 1.0×	58 0.7×	18	831

Countries citing papers authored by Sally Bebawy

Since Specialization

Citations

This map shows the geographic impact of Sally Bebawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Bebawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Bebawy more than expected).

Fields of papers citing papers by Sally Bebawy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Bebawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Bebawy. The network helps show where Sally Bebawy may publish in the future.

Co-authorship network of co-authors of Sally Bebawy

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Bebawy. A scholar is included among the top collaborators of Sally Bebawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Bebawy. Sally Bebawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giganti, Mark J, Pamela A. Shaw, Guanhua Chen, et al.. (2020). Accounting for dependent errors in predictors and time-to-event outcomes using electronic health records, validation samples and multiple imputation. The Annals of Applied Statistics. 14(2). 1045–1061. 19 indexed citations

Lee, James T., Aaron M. Kipp, Bryan E. Shepherd, et al.. (2019). Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-Cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV. AIDS and Behavior. 24(4). 1275–1280. 8 indexed citations

Rebeiro, Peter F., Tristan D. McPherson, Kathryn Goggins, et al.. (2018). Health Literacy and Demographic Disparities in HIV Care Continuum Outcomes. AIDS and Behavior. 22(8). 2604–2614. 29 indexed citations

Rebeiro, Peter F., Chanelle J. Howe, Sally Bebawy, et al.. (2018). The relationship between adverse neighborhood socioeconomic context and HIV continuum of care outcomes in a diverse HIV clinic cohort in the Southern United States. AIDS Care. 30(11). 1426–1434. 25 indexed citations

Rebeiro, Peter F., Megan Turner, Sally Bebawy, et al.. (2017). Trends in HIV Continuum of Care Outcomes over Ten Years of Follow-Up at a Large HIV Primary Medical Home in the Southeastern United States. AIDS Research and Human Retroviruses. 33(10). 1027–1034. 11 indexed citations

Kipp, Aaron M., Peter F. Rebeiro, Bryan E. Shepherd, et al.. (2017). Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care. AIDS and Behavior. 21(7). 1996–2004. 32 indexed citations

Scott, Sarah, Cathy A. Jenkins, Peter F. Rebeiro, et al.. (2017). Association Between Patient Portal Access and Viral Suppression Among People Living with HIV in a Large Southeastern Clinical Cohort. Open Forum Infectious Diseases. 4(suppl_1). S40–S40.

Turner, Megan, Cathy A. Jenkins, Sally Bebawy, et al.. (2017). Weight Gain After Switch from Efavirenz-Based to Integrase Inhibitor-Based Regimens. Open Forum Infectious Diseases. 4(suppl_1). S433–S433.

Turner, Megan, Peter F. Rebeiro, Bryan E. Shepherd, et al.. (2017). Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes. 76(5). 527–531. 225 indexed citations

10.

Castilho, Jessica L., Paula M. Luz, Bryan E. Shepherd, et al.. (2015). HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts. Infectious Agents and Cancer. 10(1). 4–4. 22 indexed citations

11.

Castilho, Jessica L., Bryan E. Shepherd, John R. Koethe, et al.. (2015). CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy. AIDS. 30(6). 899–908. 78 indexed citations

12.

Castilho, Jessica L., Cathy A. Jenkins, Bryan E. Shepherd, et al.. (2015). Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women. Journal of Women s Health. 24(6). 481–488.

13.

Qian, Han-Zhu, Sally Bebawy, Catherine C. McGowan, et al.. (2014). Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report. BMC Infectious Diseases. 14(1). 508–508. 11 indexed citations

14.

Turner, Megan, et al.. (2014). Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy. HIV Medicine. 16(1). 67–72. 14 indexed citations

15.

Lee, James, Bryan E. Shepherd, John R. Koethe, et al.. (2014). 1605Active Marijuana Use Was Not Associated with Changes in Body Mass Index or CD4 T-Cell Countsi n HIV-Infected Patients. Open Forum Infectious Diseases. 1(suppl_1). S428–S428. 1 indexed citations

16.

Koethe, John R., Aihua Bian, Ayumi Shintani, et al.. (2013). Circulating Interleukin-6, Soluble CD14, and Other Inflammation Biomarker Levels Differ Between Obese and Nonobese HIV-Infected Adults on Antiretroviral Therapy. AIDS Research and Human Retroviruses. 29(7). 1019–1025. 36 indexed citations

17.

Shepherd, Bryan E., Cathy A. Jenkins, Samuel E. Stinnette, et al.. (2010). Postpartum Discontinuation of Antiretroviral Therapy and Risk of Maternal AIDS-Defining Events, Non-AIDS–Defining Events, and Mortality Among a Cohort of HIV-1–Infected Women in the United States. AIDS Patient Care and STDs. 24(5). 279–286. 13 indexed citations

18.

Shepherd, Bryan E., Cathy A. Jenkins, Peter F. Rebeiro, et al.. (2010). Estimating the Optimal CD4 Count for HIV-infected Persons to Start Antiretroviral Therapy. Epidemiology. 21(5). 698–705. 11 indexed citations

19.

Shepherd, Bryan E., Todd Hulgan, Peter F. Rebeiro, et al.. (2009). Race and Sex Differences in Antiretroviral Therapy Use and Mortality among HIV‐Infected Persons in Care. The Journal of Infectious Diseases. 199(7). 991–998. 89 indexed citations

20.

Rebeiro, Peter F., Asghar Kheshti, Sally Bebawy, et al.. (2008). Increased Detectability of Plasma HIV‐1 RNA after Introduction of a New Assay and Altered Specimen‐Processing Procedures. Clinical Infectious Diseases. 47(10). 1354–1357. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact